Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline.

By M. Fleseriu, I. Hashim, N. Karavitaki, S. Melmed, M. H. Murad, R. Salvatori, M. Samuels. Journal of Clinical Endocrinology and Metabolism, 2016

766 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update (2021, background): “TSH, in particular, is not helpful in monitoring therapy with levothyroxine in patients with central hypothyroidism, and FT4 should be used instead.(130)”
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline (2018, background): “TSH, therefore, is not helpful in monitoring therapy with levothyroxine in central hypothyroidism, and FT4 should be used instead.(64)”
Consensus on Diagnosis and Management of Cushing’s Disease: A Guideline Update (2021, neutral): “7,136 As remission could be delayed, monitoring until postoperative cortisol nadir can usually identify such cases.”